BackgroundRisk stratification of patients with stable chronic heart failure (CHF) is critical to better identify those who may benefit the most from invasive strategies such as heart transplantation.MethodsTo improve cardiovascular (CV) death prediction in CHF, we performed a proteomic analysis using high throughput surface enhanced laser desorption ionization – time of fight – mass spectrometry (SELDI-TOF-MS). Plasma samples were pre-treated to access the deep proteome. The proteomic analysis was first performed in a case (CV death within 3 years) /control (survivors at 3 years) study including 198 patients with a left ventricular ejection fraction (LVEF) <45%. A proteomic score was developed in this derivation population using the support...
Background: Detection of preclinical cardiac dysfunction and prognosis of left ventricular heart fai...
Aims: Chronic heart failure (CHF) is a systemic syndrome with a poor prognosis and a need for novel ...
Aims To provide insights into pathogenesis of disease progression and potential novel treatment tar...
<div><p>Risk stratification of patients with systolic chronic heart failure (HF) is critical to bett...
Risk stratification of patients with systolic chronic heart failure (HF) is critical to better ident...
BACKGROUND: It remains unclear whether the plasma proteome adds value to established predictors in h...
Background: It remains unclear whether the plasma proteome adds value to established predictors in h...
Background: the ability to predict mode, as well as risk, of death in left ventricular systolic dysf...
International audienceHeart failure (HF) remains a main cause of mortality worldwide. The most commo...
Background Identifying the mechanistic pathways potentially associated with incident heart failure (...
Patients with heart failure (HF) and coronary artery disease (CAD) have a high risk for cardiovascul...
Aims: Cardiac allograft vasculopathy (CAV) is the major long‐term complication after heart transplan...
International audienceHeart failure (HF) remains a main cause of mortality worldwide. Risk stratific...
In a previous cross-sectional study, we identified a multidimensional urinary classifier (HF1), whic...
Background: Identifying the mechanistic pathways potentially associated with incident heart failu...
Background: Detection of preclinical cardiac dysfunction and prognosis of left ventricular heart fai...
Aims: Chronic heart failure (CHF) is a systemic syndrome with a poor prognosis and a need for novel ...
Aims To provide insights into pathogenesis of disease progression and potential novel treatment tar...
<div><p>Risk stratification of patients with systolic chronic heart failure (HF) is critical to bett...
Risk stratification of patients with systolic chronic heart failure (HF) is critical to better ident...
BACKGROUND: It remains unclear whether the plasma proteome adds value to established predictors in h...
Background: It remains unclear whether the plasma proteome adds value to established predictors in h...
Background: the ability to predict mode, as well as risk, of death in left ventricular systolic dysf...
International audienceHeart failure (HF) remains a main cause of mortality worldwide. The most commo...
Background Identifying the mechanistic pathways potentially associated with incident heart failure (...
Patients with heart failure (HF) and coronary artery disease (CAD) have a high risk for cardiovascul...
Aims: Cardiac allograft vasculopathy (CAV) is the major long‐term complication after heart transplan...
International audienceHeart failure (HF) remains a main cause of mortality worldwide. Risk stratific...
In a previous cross-sectional study, we identified a multidimensional urinary classifier (HF1), whic...
Background: Identifying the mechanistic pathways potentially associated with incident heart failu...
Background: Detection of preclinical cardiac dysfunction and prognosis of left ventricular heart fai...
Aims: Chronic heart failure (CHF) is a systemic syndrome with a poor prognosis and a need for novel ...
Aims To provide insights into pathogenesis of disease progression and potential novel treatment tar...